Han George
Cutis. 2014 May;93(5):E21-7.
Biologic agents, or protein-based drugs derived from living cells, are becoming commonplace in dermatology for the treatment of psoriasis, but their use spans many dermatologic conditions beyond psoriasis and psoriatic arthritis. In recent years, there has been considerable interest in their use for other inflammatory skin diseases. This article will review currently available data and reports on the off-label use of biologics in the treatment of cutaneous diseases other than psoriasis, including inflammatory dermal processes, autoimmune bullous skin diseases, connective-tissue diseases, and hidradenitis suppurativa (HS).
生物制剂,即源自活细胞的蛋白质类药物,在皮肤科治疗银屑病方面正变得越来越普遍,但其应用范围涵盖了许多除银屑病和银屑病关节炎之外的皮肤病。近年来,人们对其用于治疗其他炎症性皮肤病产生了浓厚兴趣。本文将综述目前可用的数据以及关于生物制剂在治疗除银屑病之外的其他皮肤病(包括炎症性皮肤病变、自身免疫性大疱性皮肤病、结缔组织病和化脓性汗腺炎)时的超说明书用药情况的报告。